WAUKEGAN, Ill.--(BUSINESS WIRE)--May 5, 2006--NeoPharm, Inc. (Nasdaq:NEOL - News): The Company reported a first quarter 2006 net loss of approximately $8.1 million, or $0.30 per basic and diluted share. The first quarter loss represents a $2.8 million, or 26%, improvement compared to the $10.9 million loss, or $0.46 per basic and diluted share, in the first quarter of 2005. Additionally, the first quarter 2006 results represent a $1.6 million, or 16% improvement to the $9.7 million, or $0.41 loss per basic and diluted share, when compared to the fourth quarter of 2005.
